EFFECTS OF 4 WEEKS OF HIGH INTENSITY INTERVAL TRAINING ON AUTONOMIC BALANCE IN ADULTS CONFINED BY COVID-19

Objective;to analyze the short-term effects of a 4-week High Intensity Interval Training (HIIT) on heart rate variability (HRV) remotely targeted young adults confined by COVID-19. Material and Methods;Short-term comparative descriptive cross-sectional study. Fifteen adults, normal weight, physically active with normal sleep quality, evaluated in Body Mass Index (BMI), Metabolic equivalent of task (METs) and Pittsburgh Sleep Quality Index (PSQI) prior intervention participated. A HIIT 30:30 program was developed for 4 weeks, where 2 times a week for a period of 5 min duration, the low frequency (LF), high frequency (HF), LF/HF ratio and standard deviation of the instantaneous variation of the RR intervals (SD1). Results;The LF (p = 0.96;d = 0.01), HF (p = 0.96;d = 0.01), LF/HF (p = 0.57;d = 0.08) and SD1 (p = 0.40;d = 0.15) did not report significant mean changes before and after evaluation. Conclusion;a 4-week 30:30 HIIT protocol is not an effective stimulus to generate acute and chronic adaptations to the HRV, being the slight tendency towards normal values of HRV a key indicator in the prevention of sedentary lifestyle generated by the measures of confinement by COVID-19. © 2022 Didactic Asociation Andalucia. All rights reserved.

The role of vitamin D on the risk of SARS-Cov-2/covid-19 part I: Narrative review

The objective of this review was to update the evidence on the role of vitamin D and its possible mechanisms of action on COVID-19. At present, multiple pleiotropic benefits associated with vitamin D have been suggested, among which a possible immunomodulatory effect with anti-inflammatory potential has been suggested on respiratory viral infections such as SARS-CoV-2, responsible for the COVID-19 pandemic. In this sense, current scientific evidence raises a possible association between vitamin D insufficiency (<30 ng/ml) and the risk of COVID-19 illness, in such a way that the most accepted recommendations by the scientific community suggests that supplementation not exceed the recommended dietary intake (600-800 IU/day) for healthy populations and between 400-2.000 IU/day for populations at risk of deficiency. On the other hand, scientific evidence does not recommend systematic supplementation> 4.000 IU/day, only supporting these recommendations in risk conditions in populations with confirmed insufficient levels. This review concludes that in the various countries, such as Chile, whose availability of foods rich in vitamin D is scarce should try to supply food to combat food insecurity and vitamin deficiencies related to the incidence of COVID-19. For countries whose sanitary measures prevent the population from having food that allows obtaining or maintaining sufficient levels (>30 ng/ml), supplementation between 400 and 2.000 IU/day of vitamin D is suggested. However, these associations are still controversial, more randomized clinical trials are needed to make clinical decisions.

The role of vitamin D on the risk of SARS-CoV-2 / COVID-19 part II: Requirements of vitamin D in boys, girls and adolescents

The objective of this narrative review was to analyze the results of the recently published literature on the role of vitamin D and its possible association with the mechanisms of action on COVID-19 in children and adolescents. The following databases were consulted: Medline / Pubmed, CENTRAL, Scopus, SciELO and the Google Scholar search engine in April 2021. The search strategy was carried out combining the use of Boolean operators ("AND", "OR") using the following words: COVID-19;SARS-CoV-2;Vitamin;Vitamin D;Deficiency;Pediatrics. Child;Adolescent. The recommendations of various organizations suggest a supplementation of between 400 to 1.000 IU / day to maintain or obtain a sufficient serum level (> 30 ng / ml) in children and adolescents, the evidence suggesting a possible relationship between insufficiency states (<30 ng / ml) with incidence and evolution of COVID-19. This narrative review concludes that there is a probable association between vitamin D insufficiency with the incidence and evolution of COVID-19, even when these associations are controversial as a result of the scant evidence for the population studied. More randomized clinical trials are required to allow clinical decisions to be made.